M. Frezza

发表

Anti-tumor activity of N-thiolated beta-lactam antibiotics.

Di Chen, Q. Dou, Aslamuzzaman Kazi, 2008, Cancer letters.

Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.

Di Chen, Q. Dou, C. Verani, 2009, Inorganic chemistry.

Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome.

Q. Dou, C. Verani, B. Mcgarvey, 2009, European journal of medicinal chemistry.

Synthetic Analogs of (−)-Epigallocatechin-Gallate: Bioavailability and Molecular Mechanisms of Action

Di Chen, T. Chan, Q. Dou, 2013 .

Novel metals and metal complexes as platforms for cancer therapy.

Di Chen, Q. Dou, A. Davenport, 2010, Current pharmaceutical design.

Metal complexes, their cellular targets and potential for cancer therapy.

Di Chen, Q. Dou, V. Milacic, 2009, Current pharmaceutical design.

Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.

Di Chen, Q. Dou, C. Verani, 2007, Cancer research.

In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.

Q. Dou, B. Hemmateenejad, F. Samari, 2011, Journal of medicinal chemistry.

Activation Of Tumor Cell Death Program By Targeting The Ubiquitin-Proteasome Pathway: Significance In Cancer Treatment And Prevention

M. Frezza, 2010 .

Inhibition of tumor proteasome activity by gold–dithiocarbamato complexes via both redox‐dependent and ‐independent processes

Q. Dou, L. Ronconi, Yu-hua Fan, 2010, Journal of cellular biochemistry.

Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry.

Q. Dou, B. Yan, P. Jiao, 2010, Current medicinal chemistry.

Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring.

Di Chen, Q. Dou, E. Turos, 2008, International journal of molecular medicine.

New applications of old metal-binding drugs in the treatment of human cancer.

Q. Dou, Sara M. Schmitt, M. Frezza, 2012, Frontiers in bioscience.

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Di Chen, Q. Dou, D Chen, 2011, Current cancer drug targets.

Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.

Sara Schmitt, Q Ping Dou, Q. Dou, 2011, Current topics in medicinal chemistry.

Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.

Q. Dou, A. Davenport, Minhui Shen, 2010, International journal of molecular medicine.

Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli

Q. Dou, Huanjie Yang, M. Frezza, 2011, Journal of cellular physiology.

The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design

Di Chen, Q. Dou, M. Frezza, 2007 .